RUCAM in Drug and Herb Induced Liver Injury: The Update

被引:531
作者
Danan, Gaby [1 ]
Teschke, Rolf [2 ]
机构
[1] Pharmacovigilance Consultancy, Rue Ormeaux, F-75020 Paris, France
[2] Goethe Univ Frankfurt Main, Acad Teaching Hosp,Med Fac, Div Gastroenterol & Hepatol,Klinikum Hanau, Dept Internal Med 2, D-63450 Hanau, Germany
关键词
drug induced liver injury; drug hepatotoxicity; herb induced liver injury; herbal hepatotoxicity; drugs; herbs; dietary supplements; causality assessment; RUCAM; CIOMS; CAUSALITY ASSESSMENT METHODS; TERM-FOLLOW-UP; ACUTE HEPATITIS; BLACK COHOSH; CONSENSUS MEETINGS; GREEN TEA; INDUCED HEPATOTOXICITY; PELARGONIUM-SIDOIDES; FULMINANT-HEPATITIS; CLINICAL-FEATURES;
D O I
10.3390/ijms17010014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
RUCAM (Roussel Uclaf Causality Assessment Method) or its previous synonym CIOMS (Council for International Organizations of Medical Sciences) is a well established tool in common use to quantitatively assess causality in cases of suspected drug induced liver injury (DILI) and herb induced liver injury (HILI). Historical background and the original work confirm the use of RUCAM as single term for future cases, dismissing now the term CIOMS for reasons of simplicity and clarity. RUCAM represents a structured, standardized, validated, and hepatotoxicity specific diagnostic approach that attributes scores to individual key items, providing final quantitative gradings of causality for each suspect drug/herb in a case report. Experts from Europe and the United States had previously established in consensus meetings the first criteria of RUCAM to meet the requirements of clinicians and practitioners in care for their patients with suspected DILI and HILI. RUCAM was completed by additional criteria and validated, assisting to establish the timely diagnosis with a high degree of certainty. In many countries and for more than two decades, physicians, regulatory agencies, case report authors, and pharmaceutical companies successfully applied RUCAM for suspected DILI and HILI. Their practical experience, emerging new data on DILI and HILI characteristics, and few ambiguous questions in domains such alcohol use and exclusions of non-drug causes led to the present update of RUCAM. The aim was to reduce interobserver and intraobserver variability, to provide accurately defined, objective core elements, and to simplify the handling of the items. We now present the update of the well accepted original RUCAM scale and recommend its use for clinical, regulatory, publication, and expert purposes to validly establish causality in cases of suspected DILI and HILI, facilitating a straightforward application and an internationally harmonized approach of causality assessment as a common basic tool.
引用
收藏
页数:33
相关论文
共 169 条
[1]
Severe hepatitis induced by cyproterone acetate: role of corticosteroids. A case report [J].
Abenavoli, Ludovico ;
Milic, Natasa ;
Beaugrand, Michel .
ANNALS OF HEPATOLOGY, 2013, 12 (01) :152-155
[2]
Black Cohosh and Liver Toxicity: Is There a Relationship? [J].
Adnan, Mohammed Muqeet ;
Khan, Muhammad ;
Hashmi, Syed ;
Hamza, Muhammad ;
AbdulMujeeb, Sufyan ;
Amer, Syed .
CASE REPORTS IN GASTROINTESTINAL MEDICINE, 2014, 2014
[3]
Important Elements for the Diagnosis of Drug-Induced Liver Injury [J].
Agarwal, Vijay K. ;
McHutchison, John G. ;
Hoofnagle, Jay H. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (05) :463-470
[4]
Case Definition and Phenotype Standardization in Drug-Induced Liver Injury [J].
Aithal, G. P. ;
Watkins, P. B. ;
Andrade, R. J. ;
Larrey, D. ;
Molokhia, M. ;
Takikawa, H. ;
Hunt, C. M. ;
Wilke, R. A. ;
Avigan, M. ;
Kaplowitz, N. ;
Bjornsson, E. ;
Daly, A. K. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (06) :806-815
[5]
Accuracy of hepatic adverse drug reaction reporting in one English health region [J].
Aithal, GP ;
Rawlins, MD ;
Day, CP .
BRITISH MEDICAL JOURNAL, 1999, 319 (7224) :1541-1541
[6]
Outcome of acute idiosyncratic drug-induced liver injury:: Long-term follow-up in a hepatotoxicity registry [J].
Andrade, Raul J. ;
Lucena, M. Isabel ;
Kaplowitz, Neil ;
Garcia-Munoz, Beatriz ;
Borraz, Yolanda ;
Pachkoria, Ketevan ;
Garcia-Cortes, Miren ;
Fernandez, M. Carmen ;
Pelaez, Gloria ;
Rodrigo, Luis ;
Duran, Jose A. ;
Costa, Joan ;
Planas, Ramon ;
Barriocanal, Anabel ;
Guarner, Carlos ;
Romero-Gomez, Manuel ;
Munoz-Yague, Teresa ;
Salmeron, Javier ;
Hidalgo, Ramon .
HEPATOLOGY, 2006, 44 (06) :1581-1588
[7]
Andrade RJ, 2009, PHARMACOGENOMICS, V10, P1467, DOI [10.2217/pgs.09.111, 10.2217/PGS.09.111]
[8]
Drug-induced liver injury:: An analysis of 461 incidences submitted to the Spanish Registry over a 10-year period [J].
Andrade, RJ ;
Lucena, MI ;
Fernández, MC ;
Pelaez, G ;
Pachkoria, K ;
García-Ruiz, E ;
García-Munoz, B ;
González-Grande, R ;
Pizarro, A ;
Durán, JA ;
Jiménez, M ;
Rodrigo, L ;
Romero-Gomez, M ;
Navarro, JM ;
Planas, R ;
Costa, J ;
Borras, A ;
Soler, A ;
Salmerón, J ;
Martin-Vivaldi, R .
GASTROENTEROLOGY, 2005, 129 (02) :512-521
[9]
HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease [J].
Andrade, RJ ;
Lucena, MI ;
Alonso, A ;
García-Cortes, M ;
García-Ruiz, E ;
Benitez, R ;
Fernández, MC ;
Pelaez, G ;
Romero, M ;
Corpas, R ;
Durán, JA ;
Jiménez, M ;
Rodrigo, L ;
Nogueras, F ;
Martín-Vivaldi, R ;
Navarro, JM ;
Salmerón, J ;
de la Cuesta, FS ;
Hidalgo, R .
HEPATOLOGY, 2004, 39 (06) :1603-1612
[10]
[Anonymous], 2007, ASS RISK HEP KAV PRO